Article Text

Download PDFPDF

Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients
  1. Jens F. Rehfeld,
  2. Flemming Stadil


    Sera from 15 patients with the Zollinger-Ellison syndrome were subjected to gel filtration on Sephadex G-50 superfine columns (10 × 2000 mm). The concentration of gastrin in the effluent was determined by a sensitive radioimmunoassay.

    Immunoreactive gastrin was eluted in four components in 14 sera. (1) Component I, eluted in the same position as proinsulin, constituted 9·7 ± 1·2 (mean ± SEM)% of the total immunoreactivity. (2) Component II (`big gastrin') eluted between proinsulin and insulin constituted 57·8 ± 4·1% (mean ± SEM) of immunoreactive gastrin. In three sera with the highest concentration of gastrin, component II appeared biphasic. (3) Component III (`little gastrin') was distributed in two peaks; the first one eluted in the same position as the heptadecapeptide gastrin II made up 17·4 ± 2·7 (mean ± SEM)% of the total immunoreactivity; the second one eluted in the same position as gastrin I constituted 9·5 ± 1·3 (mean ± SEM)%. (4) Component IV (`minigastrin') was eluted immediately before the salt peak and constituted 5·6 ± 1·4 (mean ± SEM)%. In one serum only components I and II were present. After incubation with trypsin all immunoreactivity in components I and II was converted to heptadecapeptide-like gastrins.

    The findings suggest that immunoreactive gastrin in serum from Zollinger-Ellison patients is circulating in at least four components of different molecular size.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.